Peer-reviewed Publications
about Hope Bio's therapeutics
Hope Biosciences is privileged to see our cellular therapeutics at work in U.S. Food and Drug Administration (F.D.A.) - authorized research in academic, hospital, and independent clinical research organization settings throughout the United States. The publications showcased here reflect continued commitment to the most rigorous research standards.
October 2024
Open Source
Parkinson's disease
"Safety and efficacy of adipose-derived mesenchymal stem cell therapy in elderly Parkinson's disease patients: an intermediate-size expanded access program"
Elsevier, Cytotherapy
doi: 10.1016/j.jcyt.2024.09.004
December 2023
Open Source
COVID-19
"Safety of multiple intravenous infusions of adipose-derived mesenchymal stem cells for hospitalized cases of COVID-19: a randomized controlled trial"
Frontiers, Frontiers in Medicine
doi: 10.3389/fmed.2023.1321303
December 2023
Open Source
Spinal cord injury
"Functional recovery of a 41-year-old quadriplegic spinal cord injury patient following multiple intravenous infusions of autologous adipose-derived mesenchymal stem cells: a case report"
Frontiers, Frontiers in Transplantation
doi: 10.3389/frtra.2023.1287508
October 2023
Open Source
"Long haul" COVID-19
"Adipose-derived, autologous mesenchymal stem cell therapy for patients with post-COVID-19 syndrome: an intermediate-size expanded access program"
BMC, Stem Cell Research & Therapy
doi: 10.1186/s13287-023-03522-1
September 2023
Open Source
Parkinson's Disease
"Long-term, repeated doses of intravenous autologous mesenchymal stem cells for a patient with Parkinson's disease: a case report"
Frontiers, Frontiers in Neurology
doi: 10.3389/fneur.2023.1257080
March 2023
Open Source
Cerebral palsy
"Multi-Dose Hope Biosciences-Adipose-Derived Mesenchymal Stem Cell (HB-adMSC) Therapy for a Patient with Cerebral Palsy: A Case Report"
ClinMed International Library, International Journal of Stem Cell Research & Therapy
doi: 10.23937/2469-570X/1410078
September 2022
Open Source
Lupus
"Frequency-dependent effect of intravenous administration of human adipose-derived mesenchymal stem cell therapy for severe Systemic Lupus Erythematosus: A case report"
Elsevier, Journal of Translational Autoimmunity
doi: 10.1016/j.jtauto.2022.100166
March 2022
Open Source
Rheumatoid Arthritis
"Safety and efficacy of autologous, adipose-derived mesenchymal stem cells in patients with rheumatoid arthritis: a phase I/IIa, open-label, non-randomized pilot trial"
BMC, Stem Cell Research & Therapy
doi: 10.1186/s13287-022-02763-w
November 2019
Open Source
Traumatic brain injury (TBI)
"Human adipose-derived mesenchymal stem
cells for acute and sub-acute TBI"
PloS ONE
doi: 10.1371/journal.pone.0233263
Want more reading?
